Mode
Text Size
Log in / Sign up

Hemithyroidectomy is associated with a 3% higher risk difference in cancer recurrence rateHemithyroidectomy linked to higher thyroid cancer recurrence

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that hemithyroidectomy is associated with a 3% higher risk difference in cancer recurrence rate compared to total thyroidectomy.

This systematic review and meta-analysis evaluated the impact of surgical technique on cancer recurrence in patients diagnosed with differentiated thyroid carcinoma (DTC). The study pooled data from a large population totaling 98,604 patients. Within this cohort, 75,531 patients underwent total thyroidectomy (TT) and 23,073 patients underwent hemithyroidectomy (HT). The primary objective was to determine the risk difference in cancer recurrence rates between these two surgical approaches.

The study compared the intervention of hemithyroidectomy against the comparator of total thyroidectomy. While specific dosing or postoperative protocols were not detailed in the meta-analysis, the focus remained on the anatomical extent of the thyroidectomy and its subsequent impact on disease recurrence. The analysis specifically looked at recurrence prevalence (RP) for both groups and calculated an odds ratio to quantify the risk associated with HT.

The primary outcome of interest was the risk difference (RD) in cancer recurrence rate. The results indicated a 3% higher recurrence rate in the HT group compared to the TT group, with a 95% CI of 3-4 and an I2 of 87%. Regarding recurrence prevalence, the data showed 5.8% for patients who underwent TT and 8.1% for those who underwent HT. The odds ratio (OR) comparing HT with TT was 1.56, with a 95% CI of 1.47-1.66 and an I2 of 85%. These figures indicate a statistically significant higher risk of recurrence following hemithyroidectomy.

Safety and tolerability data, including specific adverse event rates or discontinuation rates, were not reported for this meta-analysis. The focus remained strictly on the oncological outcome of recurrence rather than surgical complications or patient tolerance of the procedures.

These results provide a quantitative basis for evaluating surgical decisions in differentiated thyroid carcinoma. While previous literature has established various risk factors, such as lymph node ratios, these findings specifically highlight the impact of the extent of thyroidectomy. The high I2 values (87% and 85%) suggest significant heterogeneity among the included studies.

A primary limitation of this study is that all included studies were retrospective in nature. This design can introduce selection bias and may not perfectly reflect prospective clinical outcomes. Furthermore, specific follow-up durations were not reported, which could impact the interpretation of recurrence timing.

Clinically, these results suggest that thyroid specialists should consider the higher recurrence rate associated with hemithyroidectomy when tailoring initial treatment strategies for patients with differentiated thyroid carcinoma. The 3% risk difference and 1.56 odds ratio provide a clear metric for weighing the benefits of less invasive surgery against the risks of increased recurrence. Several questions remain unanswered regarding the specific patient characteristics that might influence these outcomes, such as tumor size or location. Additionally, the lack of reported follow-up times means it is unclear if recurrences occurred early or late post-surgery. Future research may clarify whether specific subsets of patients can safely undergo hemithyroidectomy without a significant increase in recurrence risk.

How this fits prior evidence

How this fits prior evidence This meta-analysis addresses the management of differentiated thyroid carcinoma by quantifying the risks associated with surgical extent. It complements existing knowledge regarding risk factors, such as the central lymph node ratio ≥0.4 identified as a key indicator for high-risk pediatric patients, by providing specific data on the impact of hemithyroidectomy versus total thyroidectomy.

For patients with differentiated thyroid carcinoma (DTC), choosing between a hemithyroidectomy (removing half the thyroid) and a total thyroidectomy (removing the whole thyroid) is a key decision. A new meta-analysis combining data from many studies looked at how often cancer comes back after each surgery. The analysis included nearly 100,000 patients, with about 75,500 having total thyroidectomy and 23,000 having hemithyroidectomy.

The results show that the chance of cancer returning is higher after hemithyroidectomy. About 8.1% of patients who had hemithyroidectomy experienced a recurrence, compared to 5.8% of those who had total thyroidectomy. This means the risk difference is about 3 percentage points higher for hemithyroidectomy. In other words, for every 100 patients treated, about 3 more would have a recurrence with hemithyroidectomy than with total thyroidectomy.

The study also calculated the odds of recurrence, which were about 1.56 times higher for hemithyroidectomy. This means that patients who had hemithyroidectomy had about a 56% higher chance of recurrence compared to those who had total thyroidectomy. However, it is important to note that this analysis is based on retrospective studies, meaning researchers looked back at past medical records rather than following patients forward in a controlled trial. This type of study can show an association but cannot prove that the surgery itself causes the difference.

Because the underlying studies are retrospective, there may be other factors that influenced which patients got which surgery. For example, patients with smaller or less aggressive tumors might have been more likely to get hemithyroidectomy, while those with larger or more aggressive tumors might have gotten total thyroidectomy. These differences could affect the recurrence rates. The meta-analysis tried to account for this, but the results should be interpreted with caution.

For patients and doctors, this information is useful when deciding on the best surgical approach. Total thyroidectomy appears to offer a lower chance of cancer coming back, but it also carries a higher risk of complications like damage to the parathyroid glands or the nerve that controls the voice. Hemithyroidectomy has fewer risks but a higher recurrence rate. The choice should be personalized based on the patient's specific tumor characteristics, overall health, and preferences.

In summary, this large meta-analysis found that hemithyroidectomy is associated with a higher recurrence rate than total thyroidectomy for differentiated thyroid cancer. The absolute difference is about 3%, meaning that for every 100 patients, 3 more would have a recurrence with the less extensive surgery. While this information is valuable, it comes from retrospective data, so further prospective studies are needed to confirm these findings and help guide treatment decisions.

What this means for you:
Hemithyroidectomy carries about a 3% higher absolute risk of cancer recurrence than total thyroidectomy for differentiated thyroid cancer.

Study Details

Study typeMeta analysis
Sample sizen = 75,531
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BACKGROUND: Differentiated thyroid carcinoma (DTC) is traditionally treated with total thyroidectomy (TT); however, hemithyroidectomy (HT) has been increasingly used. Previous analyses on DTC recurrence rate with HT and TT have yielded inconsistent results; this study aimed to bridge this gap. METHODS: Searches were conducted in PubMed/MEDLINE and Embase. Furthermore, references of previous systematic reviews were screened to extend the search until May 2025. Specific data on recurrence rate were independently extracted from the included studies by two observers and then pooled using a random-effect model. The primary endpoint was the risk difference (RD) in cancer recurrence rate between HT and TT. The secondary endpoints included recurrence prevalence (RP) for TT and HT and odds ratio (OR) comparing HT with TT. RESULTS: A total of 2,556 papers were initially identified, and 46 retrospective studies were included. The overall quality of the studies was satisfactory. In total, 98,604 patients were treated with TT (n = 75,531) or HT (n = 23,073). The proportion meta-analyses revealed a pooled RP of 5.8% in TT and 8.1% in HT. The HT group had a significantly higher probability of DTC recurrence than the TT group (OR = 1.56, 95% CI = 1.47-1.66, I 2 = 85%). The RD meta-analysis revealed that the recurrence rate was significantly higher in the HT group than in the TT group, by 3% (95% CI = 3-4, I 2 = 87%). CONCLUSION AND RELEVANCE: The DTC recurrence rate following HT is significantly higher than that observed following TT. Thyroid specialists should consider this finding when tailoring initial treatment strategies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.